Cargando…

T108. CASE REPORT OF A PATIENT WITH CATATONIA

BACKGROUND: Catatonia is a condition defined by the presence of marked psychomotor features that typically include decreased motor activity, decreased engagement or excessive or peculiar motor activity. It is frequently associated with schizophrenia, but also presents in individuals with mood disord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li Sin, Gwen, Balakrishnan, Tharmmambal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session III
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234299/ http://dx.doi.org/10.1093/schbul/sbaa029.668

Ejemplares similares

T111. GINKGO BILOBA INDUCED MOOD DYSREGULATION: A CASE REPORT
Publicado: (2020)

T4. SIGNIFICANT, PROLONGED HYPERGLYCEMIA IN AN 18-YEAR-OLD TYPE 1 DIABETIC PATIENT POST INITIATION OF ARIPIPRAZOLE: A CASE REPORT
por: Dick, Matthew, et al.
Publicado: (2020)

T84. PREMORBID ADJUSTMENT AND IQ IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS: A MULTISITE CASE-CONTROL STUDY OF THEIR RELATIONSHIP WITH CANNABIS USE
Publicado: (2020)

T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
por: Bartels-Velthuis, Annegien, et al.
Publicado: (2020)

T226. PSYCHOMETRIC INVESTIGATION OF SELF-REPORTED THOUGHT DISORDER IN NON-CLINICAL SAMPLES
por: Sumner, Philip, et al.
Publicado: (2020)

T243. MENTAL HEALTH SERVICE UTILIZATION IN YOUNG ADULTS REPORTING PSYCHOSIS-LIKE EXPERIENCES
por: Bridgwater, Miranda, et al.
Publicado: (2020)

T217. MEDICATION ADHERENCE AND ITS CORRELATES AMONG PATIENTS WITH RECURRENT SCHIZOPHRENIA: A LARGE-SCALE STUDY IN CHINA
por: Ross, Brendan, et al.
Publicado: (2020)

T220. IMPACT OF SECOND-GENERATION ANTIPSYCHOTIC SIDE EFFECTS ON FUNCTIONING FROM A SCHIZOPHRENIA PATIENT PERSPECTIVE: GLOBAL PATIENT CENTERED SURVEY INCLUDING PATIENTS FROM ITALY
por: Weiss, Catherine, et al.
Publicado: (2020)

T82. THE IMPACT OF SMOKING ON LIFE EXPECTANCY IN PSYCHOTIC DISORDERS, AN ELECTRONIC CASE REGISTER COHORT STUDY
por: Chesney, Edward, et al.
Publicado: (2020)

T152. AZERI RECENT ONSET ACUTE PHASE PSYCHOSIS SURVEY (ARAS COHORT): PRELIMINARY REPORTS FROM AN OBSERVATIONAL COHORT OF FIRST EPISODE PSYCHOSIS IN IRAN
por: Farhang, Sara, et al.
Publicado: (2020)

T210. REVIEW OF USE OF ADJUNCTIVE PSYCHOSTIMULANTS IN PATIENTS WITH SCHIZOPHRENIA: A RETROSPECTIVE STUDY
por: Zhand, Naista, et al.
Publicado: (2020)

T195. PSYCHOTIC DISORDERS IN PATIENTS WHO USE SYNTHETIC CANNABINOIDS: CLINICAL CHARACTERISTICS AND PATIENT PROFILE
por: Skriabin, Valentin, et al.
Publicado: (2020)

T114. THE CAUSAL DYNAMICS OF PARANOIA IN PATIENTS WITH SCHIZOPHRENIA: A THEORY DRIVEN NETWORK ANALYSIS
por: Bird, Jessica, et al.
Publicado: (2020)

Mode of Delivery in Patients with COVID-19
por: Miyamoto, Matthew, et al.
Publicado: (2022)

T68. RELATIONSHIP BETWEEN GLOBAL AND COGNITIVE FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA IN A GENERAL HOSPITAL IN PERU
por: Huarcaya, Jeff
Publicado: (2020)

T17. GLUTAMATE IN DORSOLATERAL PREFRONTAL CORTEX IN PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS OF 1-HMRS STUDIES
por: Kaminski, Jakob, et al.
Publicado: (2020)

T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
por: Chak Lam Yung, Nicholas, et al.
Publicado: (2020)

T132. RETINAL GANGLION CELLS DYSFUNCTIONS IN SCHIZOPHRENIA PATIENTS
por: Bernadin, Florent, et al.
Publicado: (2020)

T127. GENDER DIFFERENCES IN CLINICAL PRESENTATION AND ILLICIT SUBSTANCE USE DURING FIRST EPISODE PSYCHOSIS: AN ELECTRONIC CASE REGISTER NATURAL LANGUAGE PROCESSING ANALYSIS
por: Irving, Jessica, et al.
Publicado: (2020)

T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY
por: Tarumi, Ryosuke, et al.
Publicado: (2020)

T107. INDIVIDUALIZED DIAGNOSTIC AND PROGNOSTIC MODELS FOR PATIENTS WITH PSYCHOSIS RISK SYNDROMES: A META-ANALYTIC VIEW ON THE STATE-OF-THE-ART
por: Sanfelici, Rachele, et al.
Publicado: (2020)

T151. THE FINDINGS OF CAROTID AND CARDIAC ULTRASONOGRAPHY IN YOUNG SCHIZOPHRENIC PATIENTS
por: Tsai, Shangying, et al.
Publicado: (2020)

T218. A REAL ENVIRONMENT BASED VIRTUAL REALITY PSYCHOSOCIAL TREATMENT MAY HELP PATIENTS WITH SCHIZOPHRENIA TO INCREASE SOCIAL FUNCTIONING: A PRELIMINARY STUDY
por: Hoşgelen, Emine Ilgın, et al.
Publicado: (2020)

T190. COMPARABILITY OF PATIENT AND STUDY CHARACTERISTICS IN RANDOMIZED CONTROLLED TRIALS ON PHARMACOTHERAPY AND PSYCHOTHERAPY FOR POSITIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW
Publicado: (2020)

T158. NO ALTERATION OF PITUTARY VOLUME IN PATIENTS WITH FIRST-EPISODE SCHIZPHRENIA BUT A TREND OF ENLARGEMENT IN NON-PSYCHOTIC FIRST-DEGREE RELATIVES
por: Chu, Min-yi, et al.
Publicado: (2020)

T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES
por: Mongan, David, et al.
Publicado: (2020)

T222. IMPAIRED COST-BENEFIT COMPUTATION IN SOCIAL CONTEXT IN PATIENTS WITH SCHIZOPHRENIA
por: Yan, Chao, et al.
Publicado: (2020)

Perinatal outcomes among pregnant patients with peripartum COVID19 infection
por: Geva, Yael, et al.
Publicado: (2023)

T201. EFFECTS OF PALIPERIDONE PALMITATE ON HEALTHCARE UTILIZATION AND COSTS FOR PATIENTS WITH SCHIZOPHRENIA: A CLAIM-BASED MIRROR-IMAGE STUDY IN SOUTH KOREA
por: Hun Jung, Myung, et al.
Publicado: (2020)

T143. RESTING STATE FMRI BASED MULTILAYER NETWORK CONFIGURATION IN PATIENTS WITH SCHIZOPHRENIA
por: Gifford, George, et al.
Publicado: (2020)

T35. A PHASE 3, MULTICENTER STUDY TO ASSESS THE 1-YEAR SAFETY AND TOLERABILITY OF A COMBINATION OF OLANZAPINE AND SAMIDORPHAN IN PATIENTS WITH SCHIZOPHRENIA: RESULTS FROM THE ENLIGHTEN-2-EXTENSION
Publicado: (2020)

T86. RELEVANCE OF CANNABIS USE AS A PREDICTOR OF CLINICAL OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER PATIENTS OVER 24 MONTHS OF TREATMENT
por: Scheffler, Frederika, et al.
Publicado: (2020)

Pregnancy outcomes in patients with SARS-CoV-2 infection prior to delivery
por: Berry, Marissa J., et al.
Publicado: (2023)

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
por: Bugarski-Kirola, Dragana, et al.
Publicado: (2020)

T27. COGNITIVE RESERVE IN CHILD AND ADOLESCENT OFFSPRING OF PATIENTS DIANOSED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
por: De la Serna, Elena, et al.
Publicado: (2020)

T69. CORRELATION BETWEEN PERFORMANCE-BASED AND INTERVIEW-BASED COGNITIVE MEASUREMENTS IN PATIENTS WITH SCHIZOPHRENIA
por: Jeon, Dong-wook, et al.
Publicado: (2020)

T167. QUALITATIVE DIFFERENCES IN LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS AMONG SCHIZOPHRENIA PATIENTS
por: Karakasi, Valeria, et al.
Publicado: (2020)

T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
por: Uchida, Hiroyuki, et al.
Publicado: (2020)

T53. NEUROPHYSIOLOGICAL AND BEHAVIORAL EFFECTS OF THE STIMULATION OF NICOTINIC RECEPTORS AND NON-INVASIVE BRAIN STIMULATION IN PATIENTS WITH SCHIZOPHRENIA: STUDY DESIGN AND METHODOLOGY OF A RANDOMIZED CONTROLLED TRIAL
por: Güler, Duygu, et al.
Publicado: (2020)

889 Did institutional changes and patient behaviors surrounding COVID-19 affect perinatal outcomes?
por: Racine, Jenna L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8qugggdon7drqg9576g9113k5